FDA Law

MARCH 12, 2023

These government measures included granting temporary exemptions from certain FDA and DEA legal requirements. We will discuss the state of relevant laws prior to our new “COVID reality” and telemedicine issues during and post-pandemic, both with respect to the prescribing of controlled substances and non-controlled drugs.

Telemedicine 98

Telemedicine Government Patients Medical 98

FDA Law

OCTOBER 8, 2023

Palmer — On Friday, October 6, 2023, DEA announced a second extension of telemedicine flexibilities concerning the prescribing of controlled substances, which were originally set to expire after the end of the COVID-19 pandemic emergency. HPM’s Presentation Deck and recording of the presentation are here, and here (passcode Bv3*o^i5).

Telemedicine 64

Telemedicine Relationship IT Mental Health 64

FDA Law

NOVEMBER 15, 2022

Claud was the national coordinator of DOJ’s oversight of criminal prosecutions under the FDCA and has extensive knowledge of issues concerning corporate compliance best practices, health care fraud, telemedicine, and pharmacy compounding.

Telemedicine 52

Telemedicine Telehealth Government 52

FDA Law

NOVEMBER 21, 2024

Palmer — In a Temporary Rule announced on November 19, 2024, DEA with input from HHS again extended current telemedicine flexibilities, which were first initiated on January 31, 2020 at the inception of the COVID-19 pandemic. The federal telemedicine flexibilities (i.e.,

Telemedicine 52

Telemedicine Provider Medical Patients 52